- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 10.11.2022
- Beginn
- 11.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Axillary pain
Injection site pain
Injection site warmth
Intensive care
Symptomtext
Patient experienced hot, warmth and pain at injection site. Pain spreading to shoulder and armpits. Patient was in admitted to ICU.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Intensive care
- Hospital-Tage
- 3,0
- Labordaten
- unknown.
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- hypertension
- Andere Medikamente
- none
- Allergien
- no known allergy
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 01.12.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Decreased appetite
Dyspnoea
Gait disturbance
Headache
Musculoskeletal stiffness
Rhinorrhoea
Symptomtext
stiff neck, headache, shortness of breath, runny nose, weak, no appetite, weakness, trouble wallking
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- vitamin d
- Allergien
- demerol
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 13.05.2022
- Impfdatum
- 10.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Back pain
Chest pain
Symptomtext
I gave this patient the aforementioned 3 vaccines. He did very well, and then sat in the waiting room as directed for 15 minutes. He then walked around the store and made some purchases. After reaching his vehicle, he developed intense lower back pain and severe chest pain. He called for help and another customer ran back to the pharmacy to grab me. I ran outside and instructed an associate to call 911. He was in severe pain when i reached him, but had normal pulse and resp rate. Due to his intense chest pain, I helped the patient take 1 tablet of NTG. Shortly thereafter the squad arrived and took him to the hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- n/a, other than tests to rule our cardiovascular issues including MI.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- HTN and Diabetes
- Andere Medikamente
- losartan 50 qd NTG 0.4mg prn for chest pain
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 22.02.2023
- Beginn
- 22.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site induration
Injection site reaction
Injection site swelling
Musculoskeletal stiffness
Pain
Symptomtext
PATIENTS ARM BECAME EXTREMELY HARD, STIFF, AND SWOLLEN AT THE INJECTION SITE HOURS AFTER THE INJECTION. THE SWELLING WAS 8 INCHES ACROSS HER ARM AND 4 INCHES UP AND DOWN. PATIENT ICED THE REACTION SITE LOCALLY AND TOOK BENADYL AND IBUPROFEN FOR THE REACTION AND PAIN. PATIENT WAS ADVISED TO MONITOR REACTION AND CONTACT PCP FOR FURTHER EVALUATION AND WORKUP. THE REACTION HAS SINCE IMPROVED 2 DAYS LATER SINCE VACCINATION (2/24/23).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site induration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- STOMACH VIRUS THE DAY PRIOR
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 21.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Infection
Pain in extremity
Pyrexia
Rash
Tenderness
Symptomtext
Patient called nurse triage the morning of 11/20/22, reporting he received both the influenza and pneumonia shot, in the right arm, Friday morning 11/18/22. He had a new rash, was feverish during the night. Right arm is sore, tender. He came to the urgent care clinic connected to the pharmacy the same morning, was diagnosed with cellulitis, and given sulfamethoxazole-trimethoprim to treat the infection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Gabapentin, celecoxib, oxycodone-acetaminophen, fluticasone
- Allergien
- Rosuvastatin, morphine and related, simvastatin
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 18.11.2022
- Impfdatum
- 15.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Breast pain
Rash erythematous
Symptomtext
red rash has appeared from the left shoulder down to the elbow and deep soreness into the left breast area
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breast pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- liver cirrhosis
- Andere Medikamente
- carvediloL 3.125 mg tablet (COREG) Take 1 tablet (3.125 mg total) by mouth 2 times a day (with breakfast and dinner). ciclopirox (LOPROX) 0.77 % cream APP TOPICALLY AA ON SKIN BID ergocalciferol (vitamin D2) 1,250 mcg (50,000 unit) capsu
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 16.11.2022
- Impfdatum
- 08.11.2022
- Beginn
- 08.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Diarrhoea
Injection site hypersensitivity
Pain in extremity
Peripheral swelling
Urinary tract infection
Vomiting
Symptomtext
PATIENT HAD SWOLLEN, SORE ARM, SENSITIVE SKIN AROUND INJECTION SITE. PT ALSO HAD VOMITING AND DIARRHEA THAT MAY HAVE BEEN RELATED TO THE UTI SHE WAS DIAGNOSED WITH AT THE EMERGENCY ROOM VISIT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 02.11.2022
- Impfdatum
- 27.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Atrial fibrillation
Pain in extremity
Symptomtext
sore arm for about 24 hours then went away. Then patient's heart went into A-fib per patient
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Patient said doctor's in the hospital did tests and could only point to the cause is the vaccine
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 09.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 05.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pruritus
Injection site swelling
Symptomtext
Site: Itching at Injection Site-Mild, Site: Swelling at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 26.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Erythema
Peripheral swelling
Pyrexia
Symptomtext
Chills and low grade fever evening and late morning after vaccines. Arm swelling and redness started late that night and lasted for 5 days. Patient also received Pfizer booster vaccine and flu shot on the same day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 29.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injection site cellulitis
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
patient was diagnosed with cellulitis at ER at injection site. swollen, red, hot, painful arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 26.09.2022
- Impfdatum
- 06.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site cellulitis
Symptomtext
PATIENT HAD A CELLULITIS DEVELOP AT THE SITE OF THE INJECTION
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- OSTEOPOROSIS
- Andere Medikamente
- CYCLOBENZAPRINE, LORAZEPAM, CALCIUM, MVI
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 19.09.2022
- Beginn
- 09.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immediate post-injection reaction
Injection site erythema
Injection site haemorrhage
Injection site swelling
Symptomtext
Vaccine given IM using 25g, 1 inch needle into (L) deltoid, needle was withdrawn and area bled, bandage was applied, area immediately began to swell and turn red, Dr. was notified, bandage was removed and wiped with alcohol pad, area had stopped bleeding so bandage was left off, pt was observed for 15 minutes, redness measured 5.4 mm x 4.8 mm, swelling measured 4.5 mm x 3.5mm x 0.3mm, pt advised to apply cold compress and call or RTC if worsening symptoms or concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DM Hypercholesteremia HTN
- Andere Medikamente
- Multivitamin; Tylenol; Mobic; hydrochlorothiazide; Crestor; Gabapentin; Toujeo; Rybelsus; Metoprolol Tartrate; metformin; Chantix
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Injection site bruising
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 03.09.2022
- Impfdatum
- 29.08.2022
- Beginn
- 30.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
Site: Pain at Injection Site-Severe
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 01.09.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Discomfort
Erythema
Pyrexia
Swelling
Symptomtext
Suspected cellulitis; swelling; Arm erythema; discomfort; fever; This spontaneous report was received from pharmacist, referring to a 50-years-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-AUG-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection 0.5 milliliter at arm (lot #U027357 has been verified to be a valid lot, expiration date: 25-MAR-2023) for prophylaxis (strength, and exact anatomical location were not provided); and meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA) in the same arm (strength, dose regimen, lot #, expiration date, route of administration, and indication were not provided). On 23-AUG-2022 (also reported as "the next day, 24-AUG-2022", conflicting information), the patient experienced arm erythema, swelling, discomfort, fever and a suspected cellulitis. The physician prescribed amoxicillin (+) clavulanate potassium (AUGMENTIN) as treatment. At the time of the report, the patient had not recovered from the events. Causal relationship between the events with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA) was not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 15.08.2022
- Impfdatum
- 14.08.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
The day following vaccination the patient called the pharmacy to report the injection site area was warm, red, and swollen with injection site pain. Patient was advised to ice the area, take an oral pain reliever/fever reducer if possible, and to call the pharmacy or seek medical attention if the symptoms worsen or do not improve over the next couple of days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 11.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain
Pain in extremity
Pyrexia
Skin warm
Swelling
Symptomtext
significant swelling of right shoulder by 4 PM. fever 100 degrees by Tuesday 8/9. late afternoon. right arm sore to lift. seemed to get better Wed. on Thursday 8/11 swelling moving below elbow and redness warm. visited clinic prescribed cephalexin and prednisone
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- albuterol HFA, aspirin 81 mg, Dulera, fluticasone, montelukast, multi vitamin, pravastatin, vitamin d3
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 14.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site cellulitis
Injection site erythema
Injection site reaction
Pyrexia
Symptomtext
Injection site reaction (erythema) and fever for 24 hours - treated as cellulitis with 1 dose vancomycin and cefazolin discharged on cephalexin
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site cellulitis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- bilateral femur fractures s/p surgical correction with rod placement
- Vorgeschichte
- SCIDS like syndrome s/p bone marrow transplant, global development delay, facial dysmorphism, growth failure with microcephaly, G tube dependence, central hypothyroidism, small kidneys and chronic kidney disease,sensorineural hearing loss, generalized low bone density and multiple fractures
- Andere Medikamente
- Acetaminophen, calcium carbonate, cholecalciferol, diphenhydramine, ergocalciferol, ferrous sulfate, glycerin suppository, lactobacillus rhamnosus, levalbuterol, levothyroxine, magnesium carbonate, melatonin, mupirocin ointment, omeprazole,
- Allergien
- Peanuts - anaphylaxis; Garlic - hives; Latex - hives; Wheat
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 24.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 11.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Pain
Pyrexia
Vomiting
Symptomtext
Symptoms began next morning; body aches, fever, fatigue, vomiting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Ascending aortic aneurysm, coronary artery disease, coronary artery calcification, hypertension, hypercholesterolemia, family history of hemochrmatasis, allergic rhinitis, fatty liver, tubular adenoma of colon, bilateral hip pain, neck pain, osteoarthrosis of hand, action tremor, cervical disk disorder, parsonage-Turner syndrome, atelectasis of lung, Diaphragmatic paralysis, Male pattern baldness, snoring, overweight.
- Andere Medikamente
- Lisinopril, hydrochlorothiazide, Proscar, Zetia, turmeric, Claritin, flonase, vitamin E, Ativan, COQ10, Vitamin D3, aspirin, theragran
- Allergien
- Seasonal, contrast media, Lipitor, Crestor
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 01.11.2011
- Beginn
- 03.06.2022
- Tage bis Beginn
- 3.867,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure via eye contact
Eye pain
Syringe issue
Symptomtext
eye pain; the medication squirted out of the syringe and got on patient's eyes and face; the medication squirted out of the syringe and got on patient's eyes and face; the leakage seems to be coming from syringe's mouth/opening area but the syringe looks to be intact and no visible cracks are seen; Was there difficulty trying to attach the syringe needle to the syringe? YES; during PNEUMOVAX 23 administration today, the medication squirted out of the syringe; during PNEUMOVAX 23 administration today, the medication squirted out of the syringe; Patient Details: Patient Age: 65 year-old Patient Gender: Female ------------------------- Case Additional Information: Concomitant Medication: No additional details available Pertinent Medical History: No additional details available Drug Reactions/Allergies: No additional details available ------------------------- Primary Product Identification: Primary Product Name: pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) INJ 1DS X 10 SYRINGES 00006483703 ------------------------- Product Details #1 (Primary Product) : Product Name: pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) INJ 1DS X 10 SYRINGES 00006483703 Dose Frequency: 1 dose Product Qty: 1 Lot Number: U027357 Expiration Date: 25MAR2023 Obtain: True Hazardous Product?: True ------------------------- Adverse Event Details: Description: Caller is a medical assistant who stated that during pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) administration today, the medication squirted out of the syringe and got on patient's eyes and face. Patient has complained of eye pain but is managing symptoms by 'dabbing" on the eyes. Caller stated the leakage seems to be coming from syringe's mouth/opening area but the syringe looks to be intact and no visible cracks are seen. The syringe safety device is activated. Prior date of patient's pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) dosing was November 2011. Patient also received PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) in August 2020. Product available for return. No additional AE/PQC details are available. Lab Diagnostics/Studies Performed: No additional details available Indication: Routine vaccination Route of Administration: IM Therapy Start Date: November 2011 AE Onset Date/Date PQC First Identified: 03-JUN-2022 Recovery Date: recovering Sought Medical Attention: Yes Was Treatment given for AE?: Yes Treatment Provided: Supportive therapy of "dabbing at the eye". No other treatment provided yet Present Status: Recovering from eye pain ------------------------- PQC Details: PQC Present?: true Priority: High Risk Operator of Device: Health Professional User Experience: Repeat User QIR Requested?: False ------------------------- Notes: Note: Attachment added. CreatedDate: 03-JUN-2022 20:39:04 Note: Attachment added. CreatedDate: 03-JUN-2022 20:36:33 Note: Email received in the mailbox on 3-JUN-2022 at 3:47 pm with pictures associated with this case. Saved email as PDF as the pictures were embedded within the email. See attachment. CreatedDate: 03-JUN-2022 20:03:54 Note: Attachment added. CreatedDate: 03-JUN-2022 20:02:03 Note: QUESTION SECTION: Medium Risk: Broken Syringe Barrel High Risk: Cracked or Broken Luer Lock (Needle Attachment Issues), Broken Finger Flange. Notes for DPOC: o A cracked syringe has a line or chip in the glass, but the syringe is essentially intact in one piece. A syringe is considered broken when the syringe is in 2 or more pieces. o A syringe is also considered "cracked" if it appears to be intact with evidence of a chip or crack OR appears to be intact initially but then breaks into 2 or more pieces during use (such as while attaching a needle or injecting diluent). o Please provide a detailed description of the defect using the questions below: oIs there a crack? CALLER DOES NOT SEE A VISIBLE CRACK. WHEN TIGHTENING THE NEEDLE ONTO THE SYRINGE, CALLER STATED SHE "HEARD" A CRACK LIKE SOUND. WHEN SHE HEARD THE SOUND, SHE LOOSENS THE NEEDLE TO THE CORRECT POSITION. oIf yes, describe the size, shape & depth of the crack: CALLER UNABLE TO VIEW CRACK oProvide the exact location of the crack on the syringe: UNKNOWN TO CALLER oIs the syringe broken into 2 or more pieces? NO oIf yes, describe in detail how it is broken: (e.g. shattered, broken in half etc.) N/A oProvide the exact location of the breakage on the syringe? CALLER ASSUMES THE BREAKAGE WOULD BE AROUND THE MOUTH OF THE SYRINGE oDoes the syringe have a broken component? (e.g. broken syringe tip; loose or detached luer lock, or broken finger flange) CUSTOMER UNABLE TO CONFIRM AS CRACK IS NOT VISIBLE oIf yes, describe in detail how it is broken. oProvide the exact location of the breakage on the syringe? AROUND THE MOUTH oIs the tip of the syringe or Luer lock adaptor loose or broken off of the syringe tip? NO (if yes describe) oWas there difficulty trying to attach the syringe needle to the syringe? YES oIf yes, describe CALLER HEARD A CRACK SOUND WHEN ATTACHING THE NEEDLE oIf yes, was it supplied by MERCK: NEEDLE WAS NOT SUPPLIED BY MERCK oIf not supplied by MERCK, what type & brand, needle size & gauge was used?' 25GAUGE 1 INCHE NEEDLE. THE BRAND/COMPANY IS UNKNOWN. oUnder what situation was this defect noticed: (select one) oWhile the syringe was still in the tray? N/A oIf yes, is there product (liquid or dried residue) in the tray? N/A oIs there any broken glass or other separated component in the tray? (if yes specify) N/A oAfter removing the syringe from the tray? N/A oWhile trying to attach the needle to the syringe? YES oWhile giving the injection? YES oImmediately after giving the injection? N/A oWas the syringe tip cap attached properly prior to use? N/A oIf no, describe issue: oWas the syringe tray intact and undamaged on receipt? YES oIf no, describe damage. oIf the product came with a cellophane cover, was the cellophane covering the syringe tray intact and completely sealed? *See below. UNKNOWN TO CALLER oIf no, describe damage N/A oWas the syringe carton damaged prior to use? (i.e. crushed, ripped, unglued) UNKNOWN TO CALLER BUT THE CARTON SEEMS INTACT oIf yes, describe oWas the product administered or exposed to patient's bodily fluids (i.e. biohazardous)? YES oIf complaint sample is not/cannot be returned, please provide reason: UNIT IS AVAILABLE FOR RETURN *If photos are available, ask the customer to send them. CUSTOMER IS SENDING PICTURES Retrieval Information: oObtain product (& tray if possible) YES oExpedite return for cracked syringes. If there is a doubt whether it is cracked or broken, please expedite. NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. Complaint Description Summary Caller reported that the medication squirted out of the syringe and got on patient's eyes and face.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 13.06.2022
- Impfdatum
- 10.06.2022
- Beginn
- 10.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Vaccination site pain
Symptomtext
Severe pain in the arm including site of vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic lymphocytic leukemia
- Andere Medikamente
- None
- Allergien
- Dust Mites, Rag Weed, Molds and Smuts, Cats, Cefepime
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 02.06.2022
- Impfdatum
- 25.05.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Symptomtext
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Redness and swelling going down arm of injection to hands-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 26.05.2022
- Impfdatum
- 23.05.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Injection site erythema
Injection site swelling
Pain in extremity
Rash
Symptomtext
Patient report redness and swelling at the injection site. She also reports pain from her shoulder to her elbow and a rash that formed on 05/24/2022. As of 05/26/2022 patient reports she still has pain in the arm but the other symptoms have improved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 12.03.2022
- Impfdatum
- 10.03.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bacterial infection
Injection site swelling
Peripheral swelling
Symptomtext
Patient contacted pharmacy stating she had swelling in right arm from injection site to wrist. Patient was admitted to emergency room (ER). ER physician diagnosed her with bacterial infection. Patient was prescribed norco 10, bactrim ds, and Benadryl 25 mg.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- Emergency Roon Hospital performed test
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- sickle cell anemia
- Andere Medikamente
- folic acid 1 mg, lexapro 10 mg, ibuprofen 800 mg , hydroxyurea 500 mg
- Allergien
- macrolides and ketolides
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- -
- Geschlecht
- U
- Eingang
- 30.08.2023
- Impfdatum
- 15.08.2023
- Beginn
- 15.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AEs; Medical assistant reported that an expired PNEUMOVAX 23 was given to a patient on 8/15/2023. No additional AEs were reported. No further information provided. No PQC.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions/ allergies was not provided. On 15-AUG-2023, the patient was administered with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) pre-filled syringe, lot number: U027357, expiration date: 25-MAR-2023 (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AEs) were reported (no adverse event). No further information was provided. There was no product quality complaint (PQC).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.08.2023
- Impfdatum
- 15.08.2023
- Beginn
- 15.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; HBP calling to report the administration of an expired dose of PNEUMOVAX 23 SYRINGE to a patient on 08/15/2023. No symptoms reported and no further details provided. No other AE and no PQC; This spontaneous report was received from Other Health Professional and refers to a patient of an unspecified age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 15-AUG-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U027357, expiration date: 25-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided). On that day, the patient was administered an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23). No symptoms were reported and no further details provided. No other adverse events (AE) and no product quality complaint (PQC) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 30.06.2023
- Impfdatum
- 28.06.2023
- Beginn
- 28.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No further AE.; Nurse calls to report PNEUMOVAX 23 administered to patient after expiration date No further AE. No PQC; This spontaneous report has been received form a nurse, regarding a 65-years-old male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 28-JUN-2023, the patient was vaccinated with an expired Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, as prophylaxis (lot number: U027357, which was determined to be valid as syringe, with an expiration date on 25-MAR-2023) (strength, dose, scheme, route and anatomical location of administration were not reported). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 26.05.2023
- Impfdatum
- 11.04.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product dispensing error
Symptomtext
No additional AE reported; Patient was administered Expired PNEUMOVAX 23 on 04/11/2023; indicate at which point in the process the medication error occurred: dispensing; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported. On 11-APR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, expiration date: 25-MAR-2023, administered for prophylaxis (strength, dose lot #, and route of administration were not provided) (expired product administered). No additional adverse event (AE) was reported. This case was considered as non-valid due to lack of patient's identifiers. Follow-up information has been received from a clinic manager referring to the 81-year-old male patient on 18-MAY-2023. On 11-APR-2023, the patient was vaccinated with the first dose (number of previous doses reported as no) pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot# U027357, expiration date 25-MAR-2023, strength and dose were not reported) intramuscularly at right deltoid for prophylaxis. The operator of vaccine was a healthcare professional, and the operator was trained. The vaccine was used according to the instruction leaflet. The suspect vaccine had not been involved in any temperature excursions through the date of administration. The suspect vaccine was available for return/evaluation. The suspect vaccine had been returned to distributor. It was reported that the medication error occurred at the dispensing (product dispensing error). There was no product quality complaint. This adverse event had been reported to doctor previously. The case became valid because patient's identifier was added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.04.2023
- Impfdatum
- 11.04.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse effects reported; expired dose of PNEUMOVAX 23 was inadvertently administered to a patient; This spontaneous report was received from a 56 year old patient of unknown gender referring to himself/herself. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-APR-2023, the patient was inadvertently vaccinated with expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 ml injection, lot # U027357, expiration date: 25-MAR-2023) for prophylaxis (expired product administered). No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.04.2023
- Impfdatum
- 03.04.2023
- Beginn
- 03.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; Patient was administered expired PNEUMOVAX 23 via Corresponding PNEUMOVAX 23 Prefilled Syringe on 04/03/2023; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with expired vaccine of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) prefilled syringe injection, lot #U027357, has been verified to be a valid lot number, expiration date reported and upon internal validation established as 25-MAR-2023 (strength, route of administration, vaccination scheme frequency, anatomical location, and dose were not reported) (Expired product administered). No Temperature Excursion reported. No additional adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 4,0
- Geschlecht
- U
- Eingang
- 13.04.2023
- Impfdatum
- 10.04.2023
- Beginn
- 10.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; HCP called in to report a patient was prescribed PNEUMOVAX 23, and received an expired dose. HCP wanted to know of any adverse effects of receiving expired dose of vaccine. MIR on 02368968. No additional AE/PQC.; This spontaneous report was received from a nurse, referring to a 4-year-old patient with unknown gender. The patient's concomitant therapy, concurrent conditions, medical history and drug reactions/allergies were not reported. On 10-APR-2023, the patient was prescribed pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot number U027357 has been verified to be a valid lot number, expiration date was reported as 25-MAR-2023, 0.5 milligram (mg) /x1 only, route and anatomical location were not provided) for prophylaxis (expired product administered). No additional adverse event (AE) reported (no adverse event). The reporter wanted to know of any adverse effects of receiving expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.04.2023
- Impfdatum
- -
- Beginn
- 29.03.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported; Medical assistant transferred from Specialist reports 2 doses of expired PNUEMOVAX 23 was administered to 2 patients. Product expired 3/25/2023 and was administered today 3/29/2023. Product had not experienced any temperature excursions through the d; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 29-MAR-2023 (also reported as today), the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U027357 exp date: 25-MAR-2023) (dose and route not reported) as prophylaxis (expired product administered). Moreover, the product had not experienced any temperature excursions through the date of administration. No additional adverse events were reported (no adverse event) This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2303USA010647:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.04.2023
- Impfdatum
- 04.04.2023
- Beginn
- 04.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Patient reported no symptomatic adverse experiences/No additional AE; Nurse calling to report administration of expired PNEUMOVAX-23 to patient on 04-APR-2023. Caller stated that the product had no previous temperature excursion and expired on 25-MAR-2023; This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were no reported. On 04-APR-2023, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml once (lot # U027357, has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent), expiration date reported and validated as 25-MAR-2023) (route of administration and anatomical location were not provided) as prophylaxis (expired dose administered). The patient did not report symptomatic adverse experiences (no adverse event). No temperature excursions were reported. A "MIR" for revaccination was requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.04.2023
- Impfdatum
- 29.03.2023
- Beginn
- 29.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
no adverse event; 2 doses of expired PNUEMOVAX 23 were administered to 2 patients; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 29-MAR-2023, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U027357 exp date 25-MAR-2023) (dose and route not reported). Product had not experienced any temperature excursions through the date of administration. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2303USA010488:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.04.2023
- Impfdatum
- 30.03.2023
- Beginn
- 30.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
no additional AE's were reported; patient was administered an expired dose of PNEUMOVAX 23.; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, and concomitant therapies were not reported. On 30-MAR-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter, lot # U027357 (Lot number U027357 has been verified to be valid for pneumococcal vaccine, polyvalent [23-valent]), expiration date: 25-MAR-2023 (expired product administered) intramuscularly, as prophylaxis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 0,5
- Geschlecht
- U
- Eingang
- 27.01.2023
- Impfdatum
- 24.01.2023
- Beginn
- 24.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
No symptomatic AE. No additional AE.; Nurse reporting an AE for PNEUMOVAX 23 that was administered to a 6 month old patient.; This spontaneous report was received from a Registered Nurse regarding a 6-month-old patient of an unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 24-JAN-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 milliliter, lot #U027357, expiration date: 25-MAR-2023, (strength, anatomical location, and route of administration were not provided) administered as prophylaxis (Product administered to patient of inappropriate age). No symptomatic adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.01.2023
- Impfdatum
- 05.01.2023
- Beginn
- 05.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE.; Caller reported that PNEUMOVAX 23(syringe) that underwent a temperature excursion was administered. ?; This spontaneous report has been received from another reporter, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 05-JAN-2023, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (valid lot number U027357 [expiration date 25-MAR-2023]) (dose, vaccination scheme, route of administration, and frequency were not provided) for prophylaxis, after a temperature excursion and timeframe below 2 degrees Celsius (C) (-40.0C) for 22 hours (h) 0 minutes (min) and 0 seconds (sec). No previous temperature excursion was reported. No additional adverse events (AE) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 26.10.2022
- Impfdatum
- 06.07.2022
- Beginn
- 06.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 01.10.2022
- Impfdatum
- 19.09.2022
- Beginn
- 27.09.2022
- Tage bis Beginn
- 8,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
No additional AE reported; Nurse reported that PNEUMOVAX 23 was administered to a couple twice. This AE is for the husband. Please see AE case 02256651 for the wife. Patient received one dose of PNEUMOVAX 23 on 9/19/2022 and was accidently given a dose again of PNEUMOVAX 23 o; This spontaneous report was received from a registered nurse and refers to a 89 year old male patient. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On 19-SEP-2022, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and on 27-SEP-2022, he accidentally received another dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U027357, expiration date: 25-MAR-2023), 0.5 mL (route of administration, anatomical location not provided) for prophylaxis (extra dose administered). No additional adverse event was reported. This is one of 2 cases reported by the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 07.09.2022
- Impfdatum
- 22.08.2022
- Beginn
- 22.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Peripheral swelling
Symptomtext
Redness and Swelling to the left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Stable: Anxiety, Chronic Bronchitis, COPD, CAD, GERD, HTN, IDD-C, IDD-L, Depression, Osteoarthritis, Osteopenia, Platelet Dysfunction, Prurigo Nodularis, Vitamin D Deficiency.
- Andere Medikamente
- Albuterol HFA, Alprazolam, Amlodipine, Aspirin, Atorvastatin, Celexa, Clopidogrel, Flonase, Norco, Duo-Neb, Lansoprazole, Metoprolol, Trelegy, Vitamin B-12, Vitamin D.
- Allergien
- Betadine, Doxycycline, Flu Vaccine, PCN
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 07.09.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Alanine aminotransferase increased
Analgesic drug level therapeutic
Aspartate aminotransferase increased
Hepatitis B test negative
Hepatitis C test negative
Hepatitis viral test negative
Laboratory test normal
Symptomtext
Narrative: requiring 2 ED visits and hospitalization
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Alanine aminotransferase increased
- Hospital-Tage
- -
- Labordaten
- 03/17/2022 AST = 25, ALT = 24, 05/06/2022 AST= 320, ALT - 375 H, 05/07/2022 AST= 314, ALT = 386 H, 5/27/2022 AST = 22, ALT=19. 5/9/2022 Hepatitis ABC Panel Non Reactive, 5/7/2022 Tylenol and Salicylate levels WNL.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site discomfort
Vaccination site mass
Vaccination site swelling
Symptomtext
arm swelling; Bump the size of a tennis ball; discomfort in the arm that received the injection; This spontaneous report has been received from pharmacist concerning a 64-year-old female patient. Her concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided. On 23-AUG-2022, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe 0.5 ml/once, administered as prophylaxis, lot number U027357, expiration date 25-MAR-2023, route of administration was reported as "injection". On the same date, the patient experienced arm swelling (Vaccination site swelling), a bump the size of a tennis ball (Vaccination site mass), and discomfort in the arm that received the injection (Vaccination site discomfort) which was all referred by the patient through a call to the provider's office on 25-AUG-2022, seeking for medical attention. The patient was advised to use warm compress and to take ibuprofen as needed. At the time of the report, she had not recovered from the events. The Causal relationship between Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) and all reported events was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site discomfort
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 24.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Syringe issue
Symptomtext
HCP users have had difficulty screwing safety needles into syringe hubs and needles do no securely stay in place; No AEs r eported; HCP calling to report PQC associated with 2 lots of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23 PFS). Caller reports that HCP users have had difficulty screwing safety needles into syringe hubs and needles do no securely stay in place. On 2 occasions, the needle dislodged from the syringe hub 1) while attempting to attach safety needle cap and 2) while preparing for administration. Caller also reports that tip caps do not securely thread on to luer-lock adaptor. Caller states the issue could also be associated with 25g 1" safety needles and will file PQC for needle products as well. No AEs reported, no additional PQCs. QUESTIONS SECTION: IF REPORTED: PQC Prefilled Syringe: PQC Prefilled Syringe: Syringe Needle Defects Dull Bent Damaged Missing Syringe Needle Hub Defects Broken Wrong Color Syringe Needle Sheath Cover Defects Damaged Missing, Dislodged (High Risk) QUESTIONS SECTION: o What are the lot number(s) on the product/carton? U035117 18-AUG-2023; U027357 25-MAR-2023. NOTE: This is needed to identify the needle supplied with the kit. NO NEEDLES SUPPLIED WITH KIT o Please identify which part of the syringe needle is affected - NEEDLE ATTACHMENT, SYRINGE HUB o Please provide a detailed description of the complaint defect. NEEDLES ATTACHED TO HUB SITE ARE FALLING OUT AND CAN NOT BE SECURELY ATTACHED; SYRINGE TIP DOES NOT SECURELY FASTEN TO HUB o Under what situation was this defect noticed: (select one) o If the syringe needle is not integrated into the syringe: o Prior to removing the needle sheath? NO o After remove the needle sheath? NO o Prior to attaching the needle to the body of the syringe? NO o While attaching the needle to the syringe? YES/NO/NA/UNSPECIFIED (if yes, describe) YES, UNABLE TO SECURE NEEDLE INTO HUB o While giving the injection? YES/NO/NA/UNSPECIFIED (if yes, describe) NO o After the injection was given? YES/NO/NA/UNSPECIFIED (if yes, describe) YES, NEEDLE DISLODGED OUT OF HUB WHILE ATTEMPTINT TO SECURE SAFETY CAP AFTER INJECTION. o If Syringe needle is integrated into the body of the syringe: N/A o Prior to removing the needle sheath? N/A o After remove the needle sheath? N/A o While giving the injection? N/A o After the injection was given? N/A o If the complaint is for a dull needle: N/A o Did you/the patient allow at least one minute for the disinfectant (e.g. alcohol) to dry on your/the patient's skin before inserting the needle? N/A o Did you/the patient use an alcohol swab on the syringe needle? N/A NOTE: An alcohol swab should not be used on the syringe needle as it removes the silicone. o Did you/the patient use a "slightly" different injection site than the last injection? N/A o Have you/the patient injected yourself/herself at this injection site before? N/A o Did you/the patient insert the needle into the body at an angle of 45 degrees to 90 degrees? N/A o Did you/the patient draw blood into the syringe and need to reposition the needle without removing from the skin? N/A o How many times did you/the patient try to inject the syringe? (Note: The patient should only inject the syringe once) - N/A o Was the product dropped? NO o Was the syringe tray intact and undamaged on receipt? YES o If no, describe damage. N/A o If the product came with a cellophane cover, was the cellophane covering the syringe tray intact and completely sealed? *See below. YEs o If no, describe damage N/A o Was the syringe carton damaged prior to use? (i.e. crushed, ripped, unglued) NO o If yes, describe N/A o Was the product administered or exposed to patient's bodily fluids(i.e. biohazardous)? NO o If complaint sample is not/cannot be returned, please provide reason: 1 SYRINGE CAN BE RETURNED FROM LOT #U027357 EXP 25-MAR-2023. 2 SYRINGES FROM LOT #U035117 EXP 18-AUG-2023WERE USED AND DISPOSED. *If photos are available, ask the customer to send them Retrieval Information: o Obtain product (& tray if possible). Ensure enough absorbent material is provided to prevent breakage. NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. Sample Tracking Number: User's Experience: Repeat User Insertion Difficulty: Insertion Difficulty Details: Doubt About Presence: Doubt Details: Migration: Migration Details: Removal Problem: Removal Problem Details: 16-AUG-2022 14:30 PM :Attachment added to Service Cloud. 16-AUG-2022: Reported lot U035117 logged 16-AUG-2022; Second person reviewed 16-AUG-2022 16:30 PM :Waiting for Retrieval Site from Quality-- See attachments 16-AUG-2022 16:30 PM :Attachment added to Service Cloud. 17-AUG-2022 11:30 AM :Attachment added to Service Cloud. 17-AUG-2022 12:30 PM : Labels created for 18-AUG-2022: Upon review, both Patient Code & Device Code fields were updated. 18-AUG-2022: Second person review performed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 05.07.2022
- Impfdatum
- 30.06.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Muscle spasms
Symptomtext
PATIENT EXPERIENCED CRAMPING IN LEGS AND HAND OF LEFT SIDE OF THE BODY ON FRIDAY NIGHT. SYMPTOMS RESOLVED FOLLOWING DRINKING WATER AND RESTING AND OCCURED FOR ABOUT 24 HOURS. HAD CALF MUSCLE CRAMPING THAT WENT INTO GROIN
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Muscle spasms
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- PENICILLIN
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 22.04.2022
- Beginn
- 05.05.2022
- Tage bis Beginn
- 13,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
No additional adverse event; Caller stated the patient received two administrations of PNEUMOVAX 23- one on 4/22/2022 and the next on 5/5/2022.; This spontaneous report was received from a nurse concerning a patient (gender and age were not reported). Patient's medical history, concurrent conditions and concomitant therapies were not reported. On 22-APR--2022, the patient was vaccinated with the first dose of pneumococcal vaccine polyvalent (PNEUMOVAX-23) pre-filled syringe, 0.5 milliliter (route of administration and anatomical location were not provided), lot#U027357, expiration date reported as 18-AUG-2023, but upon internal review it was established as 25-MAY-2023 (conflicting information), as prophylaxis. Later in 05-MAY-2022 the patient was revaccinated with another dose of pneumococcal vaccine polyvalent (PNEUMOVAX-23) pre-filled syringe, 0.5 milliliter (route of administration and anatomical location were not provided), lot#U027357, expiration date 25-MAY-2023 (extra dose administered) as prophylaxis. The reported stated there were no know adverse events related to the double administration (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 03.06.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
Moderna vaccine expired by 18 hours (vaccine had been open 30 hours)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetels Mellitus type 2
- Andere Medikamente
- Metformin, calcium
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 8,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of guideline recommendations for PCV20
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- GERD; H Pylori
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of new guidelines for PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN, DM, hyperlipidemia, hypothyroidism, anemia, asthma, emphysema, OSA
- Andere Medikamente
- abilify, duoneb, aspirin, lipitor, symbicort, clindamycin, pristiq, trulicity, levothyroxine, cozaar, prilosec, vitamin D
- Allergien
- PCN, sulfa, vicodin
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 01.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of new guidelines recommending PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- asthma, acne, eczema
- Andere Medikamente
- albuterol, zyrtec, nexplanon
- Allergien
- latex
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 24.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 7,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of new guideline for PCV 20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN, hyperlipidemia, depression, anxiety, sleep apnea
- Andere Medikamente
- lipitor, baclofen, duloxetine, jardiance, vasotec, flonase, glucophage, seroquel
- Allergien
- Morphine
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 25.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of new guidelines to use PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN, diabetes, schizoaffective disorder, depression, sleep apnea
- Andere Medikamente
- Norvasc, abilify, thalitone, celexa, flonase, novolog, lantus, cozaar, zocor
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 01.06.2022
- Impfdatum
- 25.05.2022
- Beginn
- 31.05.2022
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
PPSV23 administered instead of new guideline for PCV20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 58,0
- Geschlecht
- M
- Eingang
- 23.05.2022
- Impfdatum
- 23.05.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
physician ordered pneumococcal 23 patient was due for Pneumococcal 20.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- cardiac vasculature endocrine and metabolic genitourinary reproductive
- Andere Medikamente
- metformin meloxicam tadalafil lisinopril hydroclorothiazide alfuzosin atorvastatin aspirin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 09.05.2022
- Impfdatum
- 07.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 15.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cellulitis
Symptomtext
Patient developed cellulitis down left arm after receiving vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, hyperlipidemia, ovarian failure, retinal vascular adnormality, osteoarthritis and tobacco use
- Andere Medikamente
- Lisinopril, atorvastatin ,celebrex, calcium, Vitamin D, and Humira
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 15.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Symptomtext
Patient developed cellulitis down left arm
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, hyperlipidemia, steatosis of liver, diverticulitis, menopause, impaired fasting blood sugar
- Andere Medikamente
- Atenolol, hydrochlorothiazide, citalopram, potassium, amlodipine, flonase, levocetirizine, crestor, ciloxan and xanax
- Allergien
- Lisinopril
- Vorherige Impfungen
- -
- Staat
- DE
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.04.2022
- Impfdatum
- 01.01.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 83,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
no additional AE reported; received a dose of PNEUMOVAX 23 today after they received a dose of PNEUMOVAX 23 approximately 8 to 10 weeks ago; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date approximately in January 2022 (reported as 'approximately 8 to 10 weeks ago'), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, dose number, strength, lot #, expiry date and route of administration were not provided) for prophylaxis. On 25-MAR-2022, the patient received another dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot #U027357, expiration date: 25-MAR-2023 (dose, dose number, strength and route of administration were not provided) for the same indication (Inappropriate schedule of product administration). No additional adverse events were reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -